chloroquine has been researched along with Alzheimer Disease in 28 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Excerpt | Relevance | Reference |
---|---|---|
" Further drug-like property analysis demonstrated that the optimized compound, 8d (WI-1758), had liver microsomal metabolic stability, was well tolerated (>2000 mg/kg), and had a rational pharmacokinetic profile, as well as an oral bioavailability of 14." | 1.48 | Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline-Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer's Disease. ( Chan, ASC; Feng, X; Hu, J; Huang, L; Li, X; Wang, Z; Yang, X, 2018) |
"Alzheimer's disease is the common cause of dementia characterized by the accumulation of amyloid-β produced by breakage of amyloid-β precursor protein (APP)." | 1.42 | Inhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease. ( Li, J; Zhang, FF, 2015) |
"Chloroquine treatment induced accumulation of GM1 ganglioside (GM1) in Rab5-positive enlarged early endosomes and on the cell surface." | 1.33 | Chloroquine-induced endocytic pathway abnormalities: Cellular model of GM1 ganglioside-induced Abeta fibrillogenesis in Alzheimer's disease. ( Yamamoto, N; Yanagisawa, K; Yuyama, K, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (39.29) | 18.2507 |
2000's | 5 (17.86) | 29.6817 |
2010's | 12 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rao, KV | 1 |
Donia, MS | 1 |
Peng, J | 1 |
Garcia-Palomero, E | 1 |
Alonso, D | 1 |
Martinez, A | 1 |
Medina, M | 1 |
Franzblau, SG | 1 |
Tekwani, BL | 1 |
Khan, SI | 1 |
Wahyuono, S | 1 |
Willett, KL | 1 |
Hamann, MT | 1 |
Lan, JS | 1 |
Xie, SS | 1 |
Li, SY | 1 |
Pan, LF | 1 |
Wang, XB | 2 |
Kong, LY | 2 |
Xie, S | 1 |
Chen, J | 1 |
Li, X | 3 |
Su, T | 1 |
Wang, Y | 1 |
Wang, Z | 2 |
Huang, L | 2 |
Wang, J | 1 |
Cai, P | 1 |
Yang, XL | 1 |
Li, F | 1 |
Wu, JJ | 1 |
Hu, J | 1 |
Yang, X | 1 |
Feng, X | 1 |
Chan, ASC | 1 |
Gay, M | 1 |
Carato, P | 1 |
Coevoet, M | 1 |
Renault, N | 1 |
Larchanché, PE | 1 |
Barczyk, A | 1 |
Yous, S | 1 |
Buée, L | 1 |
Sergeant, N | 1 |
Melnyk, P | 1 |
Fardet, L | 2 |
Nazareth, I | 2 |
Petersen, I | 2 |
Lee, YH | 1 |
Zhao, L | 1 |
Zhao, Y | 1 |
Tang, FL | 1 |
Xiong, L | 1 |
Su, C | 1 |
Mei, L | 1 |
Zhu, XJ | 1 |
Xiong, WC | 1 |
Wei, Y | 1 |
Zhou, J | 2 |
Wu, J | 1 |
Huang, J | 1 |
Zhang, FF | 1 |
Li, J | 1 |
Seo, BR | 1 |
Lee, SJ | 1 |
Cho, KS | 1 |
Yoon, YH | 1 |
Koh, JY | 1 |
Bendiske, J | 1 |
Bahr, BA | 1 |
Hegde, ML | 1 |
Anitha, S | 1 |
Latha, KS | 1 |
Mustak, MS | 1 |
Stein, R | 1 |
Ravid, R | 1 |
Rao, KS | 1 |
Yuyama, K | 1 |
Yamamoto, N | 1 |
Yanagisawa, K | 1 |
Refolo, LM | 1 |
Sambamurti, K | 1 |
Efthimiopoulos, S | 1 |
Pappolla, MA | 1 |
Robakis, NK | 1 |
Jensen, TG | 1 |
Roses, AD | 1 |
Jørgensen, AL | 1 |
Fuller, SJ | 1 |
Storey, E | 1 |
Li, QX | 1 |
Smith, AI | 1 |
Beyreuther, K | 1 |
Masters, CL | 1 |
Murakami, N | 2 |
Ihara, Y | 3 |
Nonaka, I | 1 |
Tsuzuki, K | 2 |
Fukatsu, R | 2 |
Takamaru, Y | 2 |
Yoshida, T | 2 |
Mafune, N | 1 |
Kobayashi, K | 2 |
Fujii, N | 2 |
Takahata, N | 2 |
Hayashi, Y | 1 |
Oyama, F | 2 |
Kouchi, Z | 1 |
Kinouchi, T | 1 |
Sorimachi, H | 1 |
Ishiura, S | 1 |
Suzuki, K | 1 |
Bi, X | 1 |
Lynch, G | 1 |
Takeuchi, IK | 1 |
Takeuchi, YK | 1 |
Gu, YJ | 1 |
Wolozin, B | 1 |
Bacic, M | 1 |
Merrill, MJ | 1 |
Lesch, KP | 1 |
Chen, C | 1 |
Lebovics, RS | 1 |
Sunderland, T | 1 |
1 review available for chloroquine and Alzheimer Disease
Article | Year |
---|---|
Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antimalarials; Brain; Chloroquine; Humans; Lysosomes; Muscles; Muscular | 1998 |
27 other studies available for chloroquine and Alzheimer Disease
Article | Year |
---|---|
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Ind | 2006 |
Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain B | 2014 |
Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cations, Divalent; Cell Membrane Permeabilit | 2015 |
Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Benzylamines; Blood-Retinal Barrier; | 2017 |
Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline-Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cell Proliferation; Drug Des | 2018 |
New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.
Topics: Alzheimer Disease; Amodiaquine; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compo | 2018 |
Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease: a population-based cohort study.
Topics: Alzheimer Disease; Antirheumatic Agents; Chloroquine; Chronic Disease; Connective Tissue Diseases; D | 2019 |
Response to: 'Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease' by Lee.
Topics: Alzheimer Disease; Chloroquine; Cohort Studies; Connective Tissue Diseases; Humans; Hydroxychloroqui | 2019 |
Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease.
Topics: Alzheimer Disease; Chloroquine; Cohort Studies; Connective Tissue Diseases; Humans; Hydroxychloroqui | 2019 |
pHluorin-BACE1-mCherry Acts as a Reporter for the Intracellular Distribution of Active BACE1 In Vitro and In Vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein | 2019 |
ERβ promotes Aβ degradation via the modulation of autophagy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Autophagy; Autophagy-Related Protein 7; Cell Line | 2019 |
Inhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease.
Topics: Adaptor Proteins, Signal Transducing; Alzheimer Disease; Autophagy-Related Proteins; Blotting, Weste | 2015 |
The zinc ionophore clioquinol reverses autophagy arrest in chloroquine-treated ARPE-19 cells and in APP/mutant presenilin-1-transfected Chinese hamster ovary cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Autophagy; Chloro | 2015 |
Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis--an approach for slowing Alzheimer disease?
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cathepsins; Chloroquine; Culture Techniq | 2003 |
First evidence for helical transitions in supercoiled DNA by amyloid Beta Peptide (1-42) and aluminum: a new insight in understanding Alzheimer's disease.
Topics: Aged; Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Apoptosis; Cell Nucleus; Chloroquine; DNA; | 2004 |
Chloroquine-induced endocytic pathway abnormalities: Cellular model of GM1 ganglioside-induced Abeta fibrillogenesis in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Chloroquine; Endocytosis; Endosomes; G(M | 2006 |
Evidence that secretase cleavage of cell surface Alzheimer amyloid precursor occurs after normal endocytic internalization.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; As | 1995 |
Apolipoprotein E uptake and degradation via chloroquine-sensitive pathway in cultivated monkey cells overexpressing low density lipoprotein receptor.
Topics: Alzheimer Disease; Animals; Apolipoproteins E; Cell Line, Transformed; Cells, Cultured; Chlorocebus | 1994 |
Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein.
Topics: Alzheimer Disease; Ammonium Chloride; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid | 1995 |
Chloroquine treated rat: a possible model for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Chloroquine; Dise | 1995 |
Co-localization of amyloid-associated proteins with amyloid beta in rat soleus muscle in chloroquine-induced myopathy: a possible model for amyloid beta formation in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antibodies; Chloroquine; Disease Models, | 1995 |
Snake coiled fibres in rat soleus muscle in chloroquine induced myopathy share immunohistochemical characteristics with amyloid depositions in Alzheimer's disease brain tissue.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Brain; Chloroquine; Disease Mod | 1997 |
The deletion of the C-terminal tail and addition of an endoplasmic reticulum targeting signal to Alzheimer's amyloid precursor protein change its localization, secretion, and intracellular proteolysis.
Topics: Adenovirus Early Proteins; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biotinylation | 1998 |
Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Cathepsin B; Cathepsin L; Cathepsins; Chloroquine; Cysteine Endope | 1999 |
Transient accumulation of Gallyas-Braak-positive and phosphorylated tau-immunopositive substances in neuronal lipofuscin granules in the amygdala, hippocampus and entorhinal cortex of rats during long-term chloroquine intoxication.
Topics: Alzheimer Disease; Amygdala; Animals; Antimalarials; Body Weight; Chloroquine; Drug Administration S | 2001 |
Simultaneous quantification of APP and tau mRNA by RT-PCR.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Chloroquine; Male; Muscle, Skeletal; Rat | 1998 |
Differential expression of carboxyl terminal derivatives of amyloid precursor protein among cell lines.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Antimetabolites; Cell Line; Chloroquine; Humans; | 1992 |